Cell therapy with bispecific antibodies

DRUG2 trials

Sponsors

Hadassah Medical Organization, Obstetrics & Gynecology Hospital of Fudan University

Conditions

Gynecological Solid TumorsMetastatic Solid Tumors

Phase 2

Immunotherapy of Cancer Using Donor Lymphocytes Labelled With In-vitro Bispecific Antibodies.

WithdrawnNCT00149019

Hadassah Medical OrganizationMetastatic Solid Tumors

Start: 2002-05-31End: 2005-09-30Target: 12Updated: 2011-04-08

Unknown Phase

A Phase I Clinical Trial of CAR-T Cells for Advanced Gynecological Solid Tumors

RecruitingNCT06904131

Obstetrics & Gynecology Hospital of Fudan UniversityGynecological Solid Tumors

Start: 2025-05-11End: 2027-12-31Target: 20Updated: 2025-04-01